Enrolling Studies


Volunteer in a research study

Contact a Hope Clinic study recruiter

COVID-19 Studies

Gritstone Vaccine Trial (DMID 20-0034)

This is a phase 1 trial to evaluate the safety, immunogenicity, and reactogenicity of a new COVID-19 vaccine.

Basic Qualifications: 

  • Healthy adults (Ages 18+)
  • Received authorized vaccine more than 4 months ago

Study Flyer

Learn More at ClinicalTrials.gov

Emory testing next-generation COVID-19 vaccines  

Observational Study of Post-Acute Sequelae of SARS-CoV-2 Infection in Adults

RECOVER researchers are studying Long COVID and other types of PASC (post-acute sequelae of SARS-CoV-2 infection). PASC is the name for all the long-term health effects that people may have after getting COVID.

Basic Qualifications: 

  • Ages 18+
  • Tested positive for COVID in the last 30 days OR controls who have never tested positive for COVID

Study Flyer

Learn More

This study seeks to understand the body’s immune response to the approved COVID-19 vaccines.

Basic Qualifications:

  • Healthy adults (Ages 18+)
  • Scheduled to receive approved COVID-19 vaccine
  • Must weigh at least 110 lbs.

To participate or for more information please call (404)712-1371 or email vaccine@emory.edu

Study Flyer

More Information on COVID-19 Studies

COVID-19 Research in the News

Vaccine and Treatment Evaluation Unit (VTEU) - Non-COVID Studies

DMID 19-0015

The purpose of this study is to test the Bexsero meningitis vaccine against the gonorrhea infection.

Basic Qualifications:

  • Healthy adults (Ages 18-49)
  • No history of gonorrhea or meningitis infection
  • Never had a meningococcal group B vaccine

To participate or for more information, please call Brittany Robinson at 404-710-4007 or send an email to vaccine@emory.edu

Study Flyer

Learn More at ClinicalTrials.gov

DMID 22-0020

The purpose of the study is to learn about the immune response of different doses and routes of administration of the approved monkeypox vaccine.

Basic Qualifications:

  • Healthy adults (Ages 18-50)
  • No history of Monkeypox or the Smallpox/Monkeypox vaccine 

To participate or for more information, please call Alexandra Koumanelis at 404-938-9819 or send an email to vaccine@emory.edu

Study Flyer

HIV Vaccine Trials Network

The purpose of this study is to evaluate the safety and tolerability of an experimental HIV vaccine. We are looking for healthy volunteers between the ages of 18 and 50. The study will involve 12 to 25 clinic visits spread out over 12 to 25 months and include several study procedures. 

To participate or for more information, please contact Rameses Frederick at rameses.frederick@emory.edu 

OR

Complete this interest form!

Sexual Health Studies

To participate or for more information about the following studies, please email us at hope.community@emory.edu or call at 877-288-0048

The CFAR Repository Study aims to store a library of samples so they are available for researchers who need them. This study is looking for HIV-negative people of any gender to participate.

The purpose of this study is to collect blood and rectal biopsy specimens from HIV infected individuals, HIV negative at-risk individuals, or HIV negative low-risk individuals to better understand HIV transmission and/or disease.

The purpose of this study is to learn more about how immune system responses in the rectum change when people take sex hormones, like estrogen and testosterone. The researchers conducting this study think that when a transgender person (someone whose gender does not match their assigned sex at birth) takes sex hormones to affirm their gender identity, this could change how their immune system responds and may increase their risk of getting infection with HIV. These changes to the immune system could also impact how well the body responds to an HIV vaccine in the future. This study will consist of 42 healthy, HIV-negative individuals (21 individuals assigned male sex at birth and 21 individuals assigned female sex at birth), aged 18-39 who do not use any hormonal treatments. Participants will undergo body site sampling, including blood and rectal sampling.

This study will test the experimental drug Lenacapavir (LEN) for the prevention of HIV infection, also known as Pre-Exposure Prophylaxis (PrEP). This study will also compare the effectiveness of LEN to Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF; Truvada®), which has already been approved in several countries for use as PrEP. Participants will recieve a HIV test. Once the results are negative, they can then be enrolled in the study. Purpose 2 is open to the trans women, trans men, gender non-conforming individuals, men who have sex with men. 

The TRANSExplore Study aims to better understand the effect of feminizing hormones on the tissues that line the rectum. Transgender women, as well as cisgender men, will be eligible to participate.

Investigator Initiated, Observational, and Other Studies

Shingrix VAX2-007

This study is being done to investigate the response of the immune system to the herpes zoster (shingles) vaccine.

Basic Qualifications:

  • Healthy adults (Ages 70+)
  • Cannot have received Shingles vaccine
  • Cannot have had Shingles infection

To participate or for more information, please call Eileen Osinski at 404-712-1371 or send an email to gosinsk@emory.edu

Study Flyer

Learn More at ClinicalTrials.gov

A clinical trial research study investigating the yellow fever vaccine. Adults who have never had the yellow fever vaccine but are planning on getting the vaccine may be eligible to participate in the study. Participants need to be between the ages of 18-45 years of age, in generally good health and must have never received the yellow fever vaccine before.  Volunteers will be compensated for all study visits.  Compensation is $75 for a screening appointment and $75 for each follow-up appointment (3-7 visits). 

To participate or for more information, please email vaccine@emory.edu or call 404-712-1371.

This study examines how the immune system responds to the flu virus (H3N2) during and after infection and how the flu virus is transmitted in the environment. 

Basic Qualifications: 

  • Healthy adults (Ages 18-49)
  • Willing to receive an influenza challenge
  • Inpatient hospital stay required (10 days)

Study Flyer

Learn More at ClinicalTrials.gov

This study is being conducted to understand how the Gardasil 9 HPV vaccine generates high levels of long-lasting antibodies in humans. 

Basic Qualifications: 

  • Healthy adults (Ages 18-45)
  • No history of HPV or HPV vaccine 

To participate or for more information, please email vaccine@emory.edu or call 404-712-1371.

Study Flyer 

Monetary compensation for time and travel varies depending on the study